Ethicon

Ethicon

Ethicon was founded in 1887 as a suture manufacturing company and became part of Johnson & Johnson in the 1940s. The firm has since expanded into a broad portfolio of surgical instruments, including mechanical staplers, energy-based surgical tools, and hemostatic agents. Ethicon's strategy centers on developing advanced surgical products for minimally invasive and open procedures. The company's asset classes include medical device R&D, manufacturing, and global distribution. Confirmed product lines include the ECHELON ENDOPATH stapler and the Harmonic scalpel. Ethicon operates across North America, Europe, Asia, and Latin America. The firm does not publicly disclose AUM or deployment numbers, as it is an operating unit of Johnson & Johnson, not an investment entity. No team size or additional offices are publicly confirmed. Ethicon does not maintain separate philanthropic vehicles distinct from Johnson & Johnson's broader corporate philanthropy. Ethicon's structural differentiator is its position as a dedicated medical device subsidiary within a diversified healthcare conglomerate. This structure provides access to extensive R&D budgets and global distribution networks, while operating as a distinct business unit with its own product-specific strategy.